Tag: Pharmaceutical manufacturers

Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, originally developed and manufactured the brand-name version of topiramate, called Topamax, receiving U.S. Food and Drug Administration (FDA) approval in 1996 for epilepsy. The medication’s initial patent protection eventually expired, paving the way for numerous companies to begin producing generic topiramate.

According to the U.S. Food and Drug Administration (FDA), several pharmaceutical companies produce generic dextroamphetamine in various formulations. An extensive list of manufacturers has received FDA approval, ensuring the availability of this treatment for conditions like ADHD and narcolepsy.